Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting

CompletedOBSERVATIONAL
Enrollment

2,013

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Hypotension
Interventions
DRUG

Cafedrine/theodrenaline

DRUG

Ephedrine

Trial Locations (75)

Unknown

Teva Investigational Site 133, Aachen

Teva Investigational Site 122, Amberg

Teva Investigational Site 106, Aue

Teva Investigational Site 116, Augsburg

Teva Investigational Site 165, Aurich

Teva Investigational Site 110, Bad Hersfeld

Teva Investigational Site 134, Bad Saarow

Teva Investigational Site 174, Bad Soden

Teva Investigational Site 142, Baden-Baden

Teva Investigational Site 121, Brake

Teva Investigational Site 146, Cologne

Teva Investigational Site 154, Dillingen

Teva Investigational Site 119, Dresden

Teva Investigational Site 171, Düsseldorf

Teva Investigational Site 111, Eichstätt

Teva Investigational Site 107, Essen

Teva Investigational Site 167, Flensburg

Teva Investigational Site 141, Friedberg

Teva Investigational Site 131, Fulda

Teva Investigational Site 114, Gelnhausen

Teva Investigational Site 158, Gelsenkirchen

Teva Investigational Site 164, Giessen

Teva Investigational Site 149, Göppingen

Teva Investigational Site 159, Greifswald

Teva Investigational Site 113, Hamburg

Teva Investigational Site 163, Hamburg

Teva Investigational Site 143, Hanover

Teva Investigational Site 144, Hanover

Teva Investigational Site 151, Hanover

Teva Investigational Site 129, Heilbronn

Teva Investigational Site 112, Herford

Teva Investigational Site 160, Hildesheim

Teva Investigational Site 132, Homburg

Teva Investigational Site 168, Idar-Oberstein

Teva Investigational Site 147, Jena

Teva Investigational Site 123, Karlsruhe

Teva Investigational Site 157, Kassel

Teva Investigational Site 104, Kempen

Teva Investigational Site 117, Leipzig

Teva Investigational Site 135, Leipzig

Teva Investigational Site 118, Leverkusen

Teva Investigational Site 102, Lingen

Teva Investigational Site 109, Ludwigsburg

Teva Investigational Site 139, Lüneburg

Teva Investigational Site 101, Marburg

Teva Investigational Site 155, Minden

Teva Investigational Site 138, Mönchengladbach

Teva Investigational Site 127, München

Teva Investigational Site 130, Münster

Teva Investigational Site 124, Neuruppin

Teva Investigational Site 152, Nuremberg

Teva Investigational Site 173, Nuremberg

Teva Investigational Site 156, Oldenburg

Teva Investigational Site 108, Pforzheim

Teva Investigational Site 136, Pirmasens

Teva Investigational Site 172, Prien am Chiemsee

Teva Investigational Site 150, Rheine

Teva Investigational Site 125, Rostock

Teva Investigational Site 169, Saalfeld

Teva Investigational Site 148, Schwalmstadt

Teva Investigational Site 166, Schwerin

Teva Investigational Site 126, Solingen

Teva Investigational Site 128, Traunstein

Teva Investigational Site 170, Trier

Teva Investigational Site 175, Ulm

Teva Investigational Site 162, Unna

Teva Investigational Site 153, Velbert

Teva Investigational Site 105, Warendorf

Teva Investigational Site 115, Wesel

Teva Investigational Site 140, Wetzlar

Teva Investigational Site 120, Wiesbaden

Teva Investigational Site 137, Worms

Teva Investigational Site 103, Würzburg

Teva Investigational Site 145, Zwiesel

Teva Investigational Site 146, Zwiesel

All Listed Sponsors
lead

Ratiopharm GmbH

INDUSTRY

NCT02893241 - Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting | Biotech Hunter | Biotech Hunter